Contrasting BioLargo (NASDAQ:BLGO) & Johnson Matthey (OTCMKTS:JMPLY)

Johnson Matthey (OTCMKTS:JMPLY) and BioLargo (NASDAQ:BLGO) are both basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

Profitability

This table compares Johnson Matthey and BioLargo’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Johnson Matthey	N/A	N/A	N/A
BioLargo	-16.53%	-58.35%	-32.12%

Valuation & Earnings

This table compares Johnson Matthey and BioLargo”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Johnson Matthey	$16.14 billion	0.22	$135.76 million	N/A	N/A
BioLargo	$12.23 million	5.83	-$3.50 million	($0.03)	-8.00

Johnson Matthey has higher revenue and earnings than BioLargo.

Institutional & Insider Ownership

0.0% of BioLargo shares are owned by institutional investors. 20.3% of BioLargo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Johnson Matthey and BioLargo, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Johnson Matthey	0	1	1	0	2.50
BioLargo	0	0	0	0	N/A

Risk and Volatility

Johnson Matthey has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, BioLargo has a beta of 0.2, meaning that its stock price is 80% less volatile than the S&P 500.

Summary

Johnson Matthey beats BioLargo on 7 of the 10 factors compared between the two stocks.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

About BioLargo

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per – and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.